FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2546717025> ?p ?o ?g. }

• W2546717025 endingPage "748.e2" @default.
• W2546717025 startingPage "739" @default.
• W2546717025 abstract "Purpose To analyze type 1 neovascular membranes in age-related macular degeneration (AMD) using optical coherence tomography (OCT) angiography, to correlate morphologic characteristics with imaging and clinical criteria, and to analyze structural features of type 1 neovascularization sequentially after anti–vascular endothelial growth factor (VEGF) therapy. Design Prospective interventional case series. Methods Macular OCT angiography images were acquired using the RTVue XR Avanti with AngioVue. Distinct morphologic patterns and quantifiable features of the neovascular membranes were studied on en face projection images at baseline and follow-up. Results Thirty-three eyes of 25 patients were included. In 75% of the eyes, a highly organized vascular complex could be identified. A large main central vessel trunk/feeder vessel could be seen in 72% of these eyes, with vessels radiating in a branching pattern either in all directions from the center of the lesion (“medusa” pattern), or from one side of the lesion (“seafan” pattern). Of the 18 eyes with follow-up OCT angiography, the lesion area and vessel density remained unchanged, even after anti–vascular endothelial growth factor (VEGF) therapy, indicating a more mature longstanding neovascular complex resistant to anti-VEGF therapy. Conclusions OCT angiography provides a unique opportunity to study the morphology of occult type 1 neovascular membranes in AMD and allows precise structural and vascular assessment noninvasively. We identified a large mature neovascular complex in approximately 75% of eyes, typically consisting of a feeder vessel and large branching vessels resistant to anti-VEGF therapy. OCT angiography may better guide evaluation and treatment of neovascular AMD, and may contribute to the development of improved therapies. To analyze type 1 neovascular membranes in age-related macular degeneration (AMD) using optical coherence tomography (OCT) angiography, to correlate morphologic characteristics with imaging and clinical criteria, and to analyze structural features of type 1 neovascularization sequentially after anti–vascular endothelial growth factor (VEGF) therapy. Prospective interventional case series. Macular OCT angiography images were acquired using the RTVue XR Avanti with AngioVue. Distinct morphologic patterns and quantifiable features of the neovascular membranes were studied on en face projection images at baseline and follow-up. Thirty-three eyes of 25 patients were included. In 75% of the eyes, a highly organized vascular complex could be identified. A large main central vessel trunk/feeder vessel could be seen in 72% of these eyes, with vessels radiating in a branching pattern either in all directions from the center of the lesion (“medusa” pattern), or from one side of the lesion (“seafan” pattern). Of the 18 eyes with follow-up OCT angiography, the lesion area and vessel density remained unchanged, even after anti–vascular endothelial growth factor (VEGF) therapy, indicating a more mature longstanding neovascular complex resistant to anti-VEGF therapy. OCT angiography provides a unique opportunity to study the morphology of occult type 1 neovascular membranes in AMD and allows precise structural and vascular assessment noninvasively. We identified a large mature neovascular complex in approximately 75% of eyes, typically consisting of a feeder vessel and large branching vessels resistant to anti-VEGF therapy. OCT angiography may better guide evaluation and treatment of neovascular AMD, and may contribute to the development of improved therapies." @default.
• W2546717025 created "2016-11-11" @default.
• W2546717025 creator A5014881844 @default.
• W2546717025 creator A5016481728 @default.
• W2546717025 creator A5018213798 @default.
• W2546717025 creator A5024845088 @default.
• W2546717025 creator A5030633237 @default.
• W2546717025 creator A5038604909 @default.
• W2546717025 creator A5043630025 @default.
• W2546717025 creator A5052383707 @default.
• W2546717025 creator A5059010928 @default.
• W2546717025 creator A5077640190 @default.
• W2546717025 date "2015-10-01" @default.
• W2546717025 modified "2023-10-16" @default.
• W2546717025 title "Optical Coherence Tomography Angiography of Type 1 Neovascularization in Age-Related Macular Degeneration" @default.
• W2546717025 cites W1964088771 @default.
• W2546717025 cites W1964823689 @default.
• W2546717025 cites W1966232476 @default.
• W2546717025 cites W1976540988 @default.
• W2546717025 cites W1992868980 @default.
• W2546717025 cites W1996137482 @default.
• W2546717025 cites W2006876183 @default.
• W2546717025 cites W2007014682 @default.
• W2546717025 cites W2010152463 @default.
• W2546717025 cites W2013425736 @default.
• W2546717025 cites W2014210274 @default.
• W2546717025 cites W2018396038 @default.
• W2546717025 cites W2041610458 @default.
• W2546717025 cites W2055153760 @default.
• W2546717025 cites W2061273505 @default.
• W2546717025 cites W2066744889 @default.
• W2546717025 cites W2070244318 @default.
• W2546717025 cites W2091467020 @default.
• W2546717025 cites W2122974013 @default.
• W2546717025 cites W2131393213 @default.
• W2546717025 cites W2160436805 @default.
• W2546717025 cites W2325901584 @default.
• W2546717025 cites W2333569680 @default.
• W2546717025 cites W2424429249 @default.
• W2546717025 cites W4233657213 @default.
• W2546717025 doi "https://doi.org/10.1016/j.ajo.2015.06.030" @default.
• W2546717025 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26164826" @default.
• W2546717025 hasPublicationYear "2015" @default.
• W2546717025 type Work @default.
• W2546717025 sameAs 2546717025 @default.
• W2546717025 citedByCount "280" @default.
• W2546717025 countsByYear W25467170252014 @default.
• W2546717025 countsByYear W25467170252015 @default.
• W2546717025 countsByYear W25467170252016 @default.
• W2546717025 countsByYear W25467170252017 @default.
• W2546717025 countsByYear W25467170252018 @default.
• W2546717025 countsByYear W25467170252019 @default.
• W2546717025 countsByYear W25467170252020 @default.
• W2546717025 countsByYear W25467170252021 @default.
• W2546717025 countsByYear W25467170252022 @default.
• W2546717025 countsByYear W25467170252023 @default.
• W2546717025 crossrefType "journal-article" @default.
• W2546717025 hasAuthorship W2546717025A5014881844 @default.
• W2546717025 hasAuthorship W2546717025A5016481728 @default.
• W2546717025 hasAuthorship W2546717025A5018213798 @default.
• W2546717025 hasAuthorship W2546717025A5024845088 @default.
• W2546717025 hasAuthorship W2546717025A5030633237 @default.
• W2546717025 hasAuthorship W2546717025A5038604909 @default.
• W2546717025 hasAuthorship W2546717025A5043630025 @default.
• W2546717025 hasAuthorship W2546717025A5052383707 @default.
• W2546717025 hasAuthorship W2546717025A5059010928 @default.
• W2546717025 hasAuthorship W2546717025A5077640190 @default.
• W2546717025 hasConcept C118487528 @default.
• W2546717025 hasConcept C126322002 @default.
• W2546717025 hasConcept C126838900 @default.
• W2546717025 hasConcept C142724271 @default.
• W2546717025 hasConcept C2776403814 @default.
• W2546717025 hasConcept C2778257484 @default.
• W2546717025 hasConcept C2778271429 @default.
• W2546717025 hasConcept C2778818243 @default.
• W2546717025 hasConcept C2780248432 @default.
• W2546717025 hasConcept C2780394083 @default.
• W2546717025 hasConcept C2780643987 @default.
• W2546717025 hasConcept C2781156865 @default.
• W2546717025 hasConcept C2781359195 @default.
• W2546717025 hasConcept C2985858981 @default.
• W2546717025 hasConcept C71924100 @default.
• W2546717025 hasConceptScore W2546717025C118487528 @default.
• W2546717025 hasConceptScore W2546717025C126322002 @default.
• W2546717025 hasConceptScore W2546717025C126838900 @default.
• W2546717025 hasConceptScore W2546717025C142724271 @default.
• W2546717025 hasConceptScore W2546717025C2776403814 @default.
• W2546717025 hasConceptScore W2546717025C2778257484 @default.
• W2546717025 hasConceptScore W2546717025C2778271429 @default.
• W2546717025 hasConceptScore W2546717025C2778818243 @default.
• W2546717025 hasConceptScore W2546717025C2780248432 @default.
• W2546717025 hasConceptScore W2546717025C2780394083 @default.
• W2546717025 hasConceptScore W2546717025C2780643987 @default.
• W2546717025 hasConceptScore W2546717025C2781156865 @default.
• W2546717025 hasConceptScore W2546717025C2781359195 @default.
• W2546717025 hasConceptScore W2546717025C2985858981 @default.
• W2546717025 hasConceptScore W2546717025C71924100 @default.
• W2546717025 hasIssue "4" @default.

• next